The Global Cancer Agenda and the Role of Patient Advocacy Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast.

Slides:



Advertisements
Similar presentations
Process and Recommendations. I. Introduction II. Process III. Key Achievement IV. Recommendations.
Advertisements

Consensus Building Workshop for an Advocacy Strategy on Population Issues in Lebanon 3 – 4 April 2006 Experiences in Advocacy: Presented by: Ms. Seta Hadeshian.
NCI Center for Global Health Jo Anne Zujewski, M.D. September 11, 2014 Dar es Salaam, Tanzania.
Breast Cancer in Eastern Europe and Central Asia Julie R. Gralow, M.D. Professor and Director, Breast Medical Oncology University of Washington School.
Mainstreaming Gender in development Policies and Programmes 2007 Haifa Abu Ghazaleh Regional Programme Director UNIFEM IAEG Meeting on Gender and MDGs.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Strategy Development for Increasing Screening Participation Awareness and Resource Mobilization The Akbaraly Foundation experience.
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
Women’s Empowerment Cancer Advocacy Network (WE CAN) Conference Global Efforts to Address the Rising Cancer Burden Dar es Salaam, Tanzania, September 2014.
Global Health Diplomacy: Advancing Health Literacy World Health Communication Associates World Health Organization - Geneva 18 May 2009 Scott C. Ratzan,
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
WHO Technical Briefing Seminar on Essential Medicines & Health Products, October 2013 Noncommunicable Diseases –Action Plan Dr Shanthi Mendis Director,
1. History of creation of STOP TB Partnership, Tajikistan Motivations: The need for joined efforts to fight TB; The voices and the needs of TB patients.
BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.
World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Global Perspective on Health Promotion Tang Kwok-cho.
Promoting patient-centred healthcare around the world Patient Engagement in Patient Safety Jolanta Bilińska Secretary and Governing Board Member IAPO President.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
Consumer Advocacy The strength of a Network: moving beyond talk to action Amanda Winiata Community Programs Manager Breast Cancer Network Australia.
Milwaukee Consortium for Hmong Health Shannon Sparks, PI Beth R. Peterman, Program Manager Pang Vang, Project Coordinator Mayhoua Moua, Lay Health Educators.
Surveillance Systems: Their Role in Identifying Risk and Resilience Factors Diego E Zavala, M.Sc., Ph.D. Associate Professor Public Health Program, Ponce.
Promoting patient-centred healthcare around the world Stephen McMahon IAPO Governing Board Member Adult Immunization: A Central Driver of Prevention and.
Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.
The Eastern European Alliance for Reproductive Choice (EEARC) was established in June 2008 thanks to support of ICMA and representatives from 11 countries,
© 2015 BHGI. All rights reserved. 1 Resource-Stratified Guidelines: A F RAMEWORK FOR C HANGE Benjamin O. Anderson, M.D. Chair and Director.
Nicolas Gorjestani, World Bank Indigenous Knowledge and Achieving the Millennium Development Goals Indigenous Knowledge -- Learning from Local Communities.
Health Information Technology Summit John Tooker, MD, MBA, FACP Executive Vice President/CEO American College of Physicians Washington, DC October 21,
1 CHRONIC CONDITION SELF-MANAGEMENT FLINDERS HUMAN BEHAVIOUR & HEALTH RESEARCH UNIT THE FLINDERS MODEL.
World Health Day Objectives Increase awareness about the rise in diabetes, and its staggering burden and consequences, in particular in low- and.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
World Health Organization Non-communicable disease prevention and control: key messages 1.Non-communicable diseases are a major public health and socio-
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
MONITORING, EVALUATION & REPORTING UPDATES 2014 Annual Partners Forum 15 April 2014.
Nick Banatvala & Pascal Bovet
Kingdom of Bahrain Dr. Naeema Isa Al Sabaeei 2014
19th Asia Pacific Regional Conference of ADI
UNESCO’s support to the Sustainable Development Goal 4 (SDG 4) on education It is a great pleasure to introduce to you the Education 2030 Framework for.
Reaching Medical Practitioners in NC
4th SOMDP July 2005 Bali, Indonesia
NCD policy and programming in Croatia
WHO’s policy priorities and projects
Interprofessional Health care Teams
Supportive Care During and After Treatment
Call for Action & International Initiative
19/05/2018 Acción Global para el Control de Cáncer Infantil Dr Oleg Chestnov Asistente Director-General Enfermedades No Comunicables y Salud Mental Organizacion.
World Health Organization
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
Katia Araujo Director of Programs Huairou Commission
prevention and control of non communicable diseases in Iraq
HEALTH IN POLICIES TRAINING
GARD/NCD Action Plan & 2011 UN Summit on NCDs
The Value of Advocacy: How to Become an Advocate for your Profession
Introduction NCONN Core Competency Area 4: Advocacy
World Hearing Day 2018 Hear the future.
Judith Watt Director, NCD Alliance
Overview of the Addiction Technology Transfer Center Network
Global Ageing and NCDS Richard Blewitt CEO HelpAge International 9 March 2012 ADI International Conference London.
Accelerating Cervical Cancer Elimination
One of the most valuable stakeholders in the GEF is civil society
LECTURE: GENDER ISSUES IN GLOBAL, REGIONAL AND NATIONAL CONTEXTS
The Alliance for Wisconsin Youth: The Role of Prevention Coalitions in Addressing Substance Use Disorders Elysse Chay, Prevention Manager Public Policy.
National Cancer Center
Social Determinants of Health
Clinical Research Network North East and North Cumbria
The Network of European Patient Advocacy Groups is the only umbrella organization for patient groups committed to gynaecological cancers. Established in.
2011 UN Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases “We, Heads of.
The only prescription with unlimited refills. Regular exercise (150 minutes per week) lowers risk of developing heart disease, high blood pressure,
Millennium Development Goals (MDGs)
The Ottawa Charter as an Effective Health Promotion Framework - Overview As you learn about the Ottawa Charter as an effective health promotion framework.
Dr Ruitai Shao Programme Management Adviser
By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.
Presentation transcript:

The Global Cancer Agenda and the Role of Patient Advocacy Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast Cancer Professor, Global Health University of Washington School of Medicine Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance

A Global Call to Action UN High-level Meeting on Prevention & Control of Non-Communicable Diseases (NCDs) September 19-20, 2011 Millennium Development Goals expired 2015Millennium Development Goals expired 2015 NCDs – cancer, cardiac, respiratory, diabetes – a major challenge to health and development in 21st centuryNCDs – cancer, cardiac, respiratory, diabetes – a major challenge to health and development in 21st century NCDs a priority for UNNCDs a priority for UN

WHO Global Monitoring Framework for Non-Communicable Diseases (NCDs) Provides a clear vision for action by 2025Provides a clear vision for action by 2025 UN Member States formally adopted the global monitoring framework at the 66th World Health Assembly in May 2013UN Member States formally adopted the global monitoring framework at the 66th World Health Assembly in May 2013 –9 global targets –25 indicators Primary Target:

UN/WHO Global Monitoring Framework for NCDs: Targets for 2025

How Can Cancer Patient Advocates Help in Improving Cancer Care Globally?

2007 U.S. Institute of Medicine Report on Cancer Control Opportunities in Low- and Middle-Income Countries Sloan FA, et al, National Academies Press, 2007 Advocacy has a key role to play in bringing the public’s concerns about cancer to decision makers Income-Countries.aspx

2007 U.S. Institute of Medicine Report on Cancer Control Opportunities in Low- and Middle-Income Countries Sloan FA, et al, National Academies Press, 2007 Summary recommendations: AdvocacySummary recommendations: Advocacy –Need to actively support and assist cancer advocacy in low- and middle-resource countries –Suggested activities: »Set up advocacy networks within countries, regions, and internationally »Identify successful approaches to cancer advocacy and replicate/adapt for use in other settings »Provide hands-on training and technical assistance

Cancer Patient Advocacy Definition: The role of patients in the area of clinical care, health policy, and researchDefinition: The role of patients in the area of clinical care, health policy, and research Patient advocacy groups can be:Patient advocacy groups can be: –Informational (share disease- and treatment- specific knowledge) –Supportive (provide medical and/or psychological support to patients and family) –Research (participate in shaping the research agenda) –Political (influence government legislative and regulatory decisions)

Women’s Empowerment Cancer Advocacy Network (WE CAN) Developed to support breast and cervical cancer patient advocacy groups in low- and middle-income countries with skills to address:Developed to support breast and cervical cancer patient advocacy groups in low- and middle-income countries with skills to address: –inadequacy in information –inequity in treatment and care –injustice in cancer early detection, screening, treatment, and prevention

WE CAN Patient Advocacy Goals Raise awareness of the impact of women’s cancers on societyRaise awareness of the impact of women’s cancers on society Provide information on breast and cervical cancer issues to promote community activismProvide information on breast and cervical cancer issues to promote community activism Establish/promote health care standards on breast and cervical cancerEstablish/promote health care standards on breast and cervical cancer Understand what women with cancer want and need, and how to address those needsUnderstand what women with cancer want and need, and how to address those needs Bring together doctors, patients and activists as equals around a common causeBring together doctors, patients and activists as equals around a common cause Connect isolated women to national and international communities for collaborationConnect isolated women to national and international communities for collaboration Engage patient-doctor dialog and focus health care to the patientEngage patient-doctor dialog and focus health care to the patient

WE CAN Eastern Europe/Central Asia Breast and Cervical Cancer Advocacy Conferences Vilnius, Lithuania 2003 Kiev, Ukraine 2005 Minsk, Belarus 2007 Bishkek, Kyrgyzstan 2009 Vilnius, Lithuania 2011 Tbilisi, Georgia 2013 Bucharest, Romania 2015 ?? 2017

WE CAN East African Breast and Cervical Cancer Advocacy Conferences Kampala, Uganda September 2013 Dar es Salaam, Tanzania October 2014 Nairobi, Kenya April 2016 April